Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Renascience Pharma Ltd, 11 George Street West, Luton, Bedfordshire, LU1 2BJ, United Kingdom
Renapime 1 g powder for solution for injection/infusion.
Renapime.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion. White to pale yellow powder. |
Renapime 1 g powder for solution for injection or infusion: One vial contains 1 g of cefepime (as dihydrochloride monohydrate).
Renapime.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cefepime |
Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases. |
| List of Excipients |
|---|
|
L-arginine |
Colourless type II 20 ml glass vial closed with chlorobutyl rubber stopper and sealed with an aluminium cap and a plastic flip-off.
Pack size: 1, 5, 10, 20, 25, 50 and 100 vials.
Not all pack sizes may be marketed.
Renascience Pharma Ltd, 11 George Street West, Luton, Bedfordshire, LU1 2BJ, United Kingdom
PL 44696/0001
08/12/2017
| Drug | Countries | |
|---|---|---|
| RENAPIME | Estonia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
